SNX10-mediated LPS sensing causes intestinal barrier dysfunction via a caspase-5-dependent signaling cascade
文献类型:期刊论文
作者 | Wang, Xu1,2; Ni, Jiahui1,2,3; You, Yan1,2; Feng, Guize1,2; Zhang, Sulin4; Bao, Weilian1,2; Hou, Hui4; Li, Haidong1,2; Liu, Lixin1,2; Zheng, Mingyue4 |
刊名 | EMBO JOURNAL |
出版日期 | 2021-11-08 |
页码 | 16 |
ISSN号 | 0261-4189 |
关键词 | E-cadherin IBD intestinal barrier function LPS release SNX10 |
DOI | 10.15252/embj.2021108080 |
通讯作者 | Zhou, Hua() ; Shen, Weixing(weixingshen@njucm.edu.cn) ; Shen, Xiaoyan(shxiaoy@fudan.edu.cn) |
英文摘要 | Altered intestinal microbial composition promotes intestinal barrier dysfunction and triggers the initiation and recurrence of inflammatory bowel disease (IBD). Current treatments for IBD are focused on control of inflammation rather than on maintaining intestinal epithelial barrier function. Here, we show that the internalization of Gram-negative bacterial outer membrane vesicles (OMVs) in human intestinal epithelial cells promotes recruitment of caspase-5 and PIKfyve to early endosomal membranes via sorting nexin 10 (SNX10), resulting in LPS release from OMVs into the cytosol. Caspase-5 activated by cytosolic LPS leads to Lyn phosphorylation, which in turn promotes nuclear translocalization of Snail/Slug, downregulation of E-cadherin expression, and intestinal barrier dysfunction. SNX10 deletion or treatment with DC-SX029, a novel SNX10 inhibitor, rescues OMV-induced intestinal barrier dysfunction and ameliorates colitis in mice by blocking cytosolic LPS release, caspase-5 activation, and downstream signaling. Our results show that targeting SNX10 may be a new therapeutic approach for restoring intestinal epithelial barrier function and promising strategy for IBD treatment. |
WOS关键词 | CROHNS-DISEASE ; SUSCEPTIBILITY LOCI ; MULTIPLE ; BINDING ; PERMEABILITY ; ACTIVATION |
资助项目 | National Natural Science Foundation of China[82130108] ; National Natural Science Foundation of China[81773744] ; National Natural Science Foundation of China[81973523] ; National Natural Science Foundation of China[81573441] ; National Natural Science Foundation of China[81371923] ; Shanghai Pujiang Program[21PJ1401400] ; Personalized Medicines-Molecular Signature-based Drug Discovery and Development, Strategic Priority Research Program of the Chinese Academy of Sciences[XDA12020368] ; State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences[SIMM1903KF-05] ; Fudan-SIMM Joint Research Fund[FU-SIMM20183002] |
WOS研究方向 | Biochemistry & Molecular Biology ; Cell Biology |
语种 | 英语 |
出版者 | WILEY |
WOS记录号 | WOS:000715243400001 |
源URL | [http://119.78.100.183/handle/2S10ELR8/298774] |
专题 | 新药研究国家重点实验室 |
通讯作者 | Zhou, Hua; Shen, Weixing; Shen, Xiaoyan |
作者单位 | 1.Fudan Univ, Sch Pharm, Dept Pharmacol, Minist Educ, Shanghai, Peoples R China 2.Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery, Minist Educ, Shanghai, Peoples R China 3.Nanjing Univ Chinese Med, Clin Med Coll 1, Jiangsu Collaborat Innovat Ctr Tradit Chinese Med, Nanjing, Peoples R China 4.Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China 5.Macau Univ Sci & Technol, Fac Chinese Med, Taipa, Macao, Peoples R China 6.Macau Univ Sci & Technol, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China |
推荐引用方式 GB/T 7714 | Wang, Xu,Ni, Jiahui,You, Yan,et al. SNX10-mediated LPS sensing causes intestinal barrier dysfunction via a caspase-5-dependent signaling cascade[J]. EMBO JOURNAL,2021:16. |
APA | Wang, Xu.,Ni, Jiahui.,You, Yan.,Feng, Guize.,Zhang, Sulin.,...&Shen, Xiaoyan.(2021).SNX10-mediated LPS sensing causes intestinal barrier dysfunction via a caspase-5-dependent signaling cascade.EMBO JOURNAL,16. |
MLA | Wang, Xu,et al."SNX10-mediated LPS sensing causes intestinal barrier dysfunction via a caspase-5-dependent signaling cascade".EMBO JOURNAL (2021):16. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。